Clinical, Laboratory, and Trichoscopic Features of Pediatric Androgenetic Alopecia

In this retrospective study, we analyzed the prevalence and impact of pediatric androgenetic alopecia (AGA). Over a 14-year period, 133 pediatric patients were evaluated, with manifestations of AGA appearing as early as age 10 years. The analysis included factors such as body mass index (BMI), family history of AGA, comorbidities, laboratory results, and patterns of hair loss. Trichoscopic differences between sexes and age groups were observed. This study underscores the importance of individualized, step-by-step, and comprehensive treatment for pediatric AGA, prioritizing hormonal disorders and concurrent conditions while managing hair loss with topical minoxidil. Topical minoxidil generally is well tolerated in pediatric patients, although close monitoring of adverse effects and timely feedback to the clinician still are necessary. More importantly, encouraging patients to adhere to their medication and attend regular follow-up appointments can yield favorable outcomes.